Gastrin is trophic to colon cancers that possess gastrin receptors. Whether fasting serum gastrin concentrations are high in patients with colon cancer is controversial. We therefore studied the effect of food on serum gastrin concentrations in patients with colon cancer and control subjects. Fasting serum gastrin was greater, though not significantly so, in patients with colon cancer before surgery (mean (SD) 17*4 (3.6) pmoVI, n=16) compared with control subjects (12.6 (1.9) pmol/l, n=14). Postprandial increases in serum gastrin were significantly and persistently higher than normal in the cancer patients. Blood samples were taken while fasting and then at 10, 20, 40, 60, 90, and 120 minutes after a standardised hospital meal. In the patients with cancer, these studies were performed on the day of admission before bowel preparation, and were repeated 10 days after surgery, immediately before hospital discharge. The blood was drawn into EDTA bottles containing 10 units of Trasylol (Bayer UK, Reading) and immediately placed on ice. Plasma was separated by centrifugation (3000 rpm for five minutes) within 30 minutes of collection and was stored at -70°C before gastrin assay.
Colon cancer is the third commonest malignant disease in the United Kingdom with some 14 000 new patients seen annually, more than half of whom will die from their cancer. It has been clear for some time that gastrin is trophic to the normal colonic mucosa of rats. ' Recent work has shown that exogenously administered gastrin is trophic to colon cancer that possesses gastrin receptors,2 3 while administration of the gastrin receptor antagonist, proglumide, prolongs tumour doubling time and increases survival in mice with xenografted colon cancer. 4 In animal models of colon carcinogenesis, endogenous hypergastrinaemia increases the number of rats that develop colon cancer' and also the growth rate of epithelial tumours. 6 Gastrin and its analogue pentagastrin stimulate the growth of human colon cancer Blood samples were taken while fasting and then at 10, 20, 40, 60, 90, and 120 minutes after a standardised hospital meal. In the patients with cancer, these studies were performed on the day of admission before bowel preparation, and were repeated 10 days after surgery, immediately before hospital discharge. The blood was drawn into EDTA bottles containing 10 units of Trasylol (Bayer UK, Reading) and immediately placed on ice. Plasma was separated by centrifugation (3000 rpm for five minutes) within 30 minutes of collection and was stored at -70°C before gastrin assay.
At surgery, samples (1 g) of tumour and healthy colonic mucosa from the distant resection margin were collected and stored dry at -70°C. These specimens were then extracted by mincing and boiling in distilled water for 30 minutes at a volume of 5 ml water/g tissue (1:5 dilution). The supernatant was separated by centrifugation and stored again at -70°C for subsequent analysis. As a positive control for our extraction procedure, samples of normal gastric antrum taken at gastric surgery were also examined for gastrin concentration.
Determination of the gastrin concentration in both serum and tissue extracts was by radioimmunoassay using antibody G179 (a gift of Professor S R Bloom) which recognises the large C terminal fragments of gastrin -that is, G-34 and G-17 -with less than 2% cross reactivity to CCK-8, CCK-33, and CCK-39.'3 The data were analysed using a two way analysis of variance (ANOVA), and where the ANOVA showed a significant difference, the groups at each time point were compared using a Student's t test (p<005 considered significant).
Results
The results of the effect of feeding on serum gastrin are summarised in Figure 1 pmolIl) but these differences were not signifi-nor would it be expected that the presence of cant. Postprandial serum gastrin concentrations, food in the stomach could promote and increase however, were persistently higher in the colon the release of gastrin from a tumour in the colon. cancer patients before surgery than in the other However, it is possible that tumours produce two groups, and these differences were signifi-a factor or factors that stimulate endogenous gastrinaemia, which resolves after resection of the tumour. Abnormally high serum gastrin concentrations after meals may have an aetiological role in the development of colon cancer, particularly in the transition from benign adenoma to carcinoma. Finally, it is possible that the colon tumours may be producing an agent that promotes abnormally excessive production of gastrin after food and this phenomenon is now being investigated by our group.
with colorectal cancer. 
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